CME income up, despite pharma cuts

Share this article:
CME income up, despite pharma cuts
CME income up, despite pharma cuts

Drug makers trimmed CME grant-giving by about 10% in 2012, the fifth consecutive annual decrease, according to ACCME data. Commercial support totaled $662 million, down from $736 million.

The decline followed the prior year's 11% drug industry cutback. Pharma has been slicing budgets for certified education for physicians since 2008.

But revenues from registration fees and the like surged nearly 15%, last year's data show, pushing total income up by 5% to $2.3 billion. That bettered the 1% decrease in total income reported by ACCME-accredited providers the prior year.

In 2012, income from these non-pharma sources made up 58% of total income for CME providers, up from 53% in 2011. This income is defined by ACCME as participant registration fees and allocations from a CME provider's parent organization or other internal departments.

Also helping to fill the void were non-physician's participants. Nurses, PAs, residents, and other health professionals boosted CME attendance by 7%, vs. a 1% increase the year prior, outshining MDs and DOs, whose participation rose by 6%.

Data showed an evening of the CME funding picture. Commercial support accounted for 28% of total reported income, down from 33% the prior year and 50% in 2006.

Industry's grant-giving tally last year is a bit lower as it excludes in-kind support, such as when a company loans a provider a device to use for teaching purposes. The ACCME decided in 2011 not to require them to quantify the dollar value of this kind of commercial support.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?